Robert E. Sulentic - 18 Feb 2022 Form 4 Insider Report for CBRE GROUP, INC. (CBRE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Feb 2022, 18:09:09 UTC
Prior SEC filing
18 Feb 2022
Next SEC filing
01 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cindy Kee, Attorney-in-Fact for Robert E. Sulentic

Key filing fact

Robert E. Sulentic filed Form 4 for CBRE GROUP, INC. (CBRE) on 23 Feb 2022.

Key facts

  • This page summarizes Robert E. Sulentic's Form 4 filing for CBRE GROUP, INC. (CBRE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Feb 2022, 18:09.

Change

  • Previous filing in this sequence was filed on 18 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CBRE transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+245,972
Change %
+33%
Price
$0.000000
Shares after
1,001,148
Date
18 Feb 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Issuer granted these securities to the Reporting Person on March 3, 2020 as part of the Reporting Person's 2020 annual equity award. On February 18, 2022, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer's Adjusted EPS performance necessary for this award to vest. As such, these securities will vest in full on March 3, 2023, subject to forfeiture in certain circumstances as set forth in the award agreement for these securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .